Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Retinal Consultants of Sacramento (RCS) is a premier clinical and research institution specializing in diseases of the retina, macula, and vitreous. Founded in 1975, the practice provides advanced diagnostic and treatment services for conditions such as age-related macular degeneration, diabetic retinopathy, and retinal detachment. RCS is nationally recognized for its robust clinical research department, having participated in over 300 national clinical trials that have contributed to the FDA approval of numerous ophthalmic therapies. The organization operates multiple locations across Northern California and is a member of the Retina Consultants of America network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Retinal Consultants of Sacramento.